DelveInsight's "XPOVIO Market Size, Forecast, and Market Insight Report" highlights the details around XPOVIO, a ...

Future Oncol. 2013;9(3):355-368. While preliminary clinical data are encouraging, the durability of responses observed with treatment with ADC-based regimens remains to be determined. Equally ...

Thrombocytopenia, which is a low platelet count, can be caused by problems in the bone marrow or the immune system. The bone marrow may not make enough platelets, or the immune system may destroy ...

Immune thrombocytopenia (ITP) is an autoimmune disease, characterized by increased bleeding due to a reduced platelet count. The pathogenesis of ITP is very complex and involves autoantibody ...

The addition of brentuximab vedotin to lenalidomide and rituximab improved survival ... in each treatment arm developed neutropenia, thrombocytopenia, diarrhea or anemia. Researchers acknowledged ...

Malignancies of B cells include lymphomas and leukemias. Lymphomas of B-cell origin constitute a diverse set of neoplasms within the larger context of non-Hodgkin's lymphoma (NHL). In the USA, B ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

COVID-19 infections were seen in 45.5% vs 35.3%, thrombocytopenia in 39.0% vs 21.2% ... III trial of venetoclax-obinutuzumab versus fludarabine, cyclophosphamide and rituximab or ...

Importantly, none of the AEs that were observed required the use of additional immunomodulatory agents such as eculizumab, sirolimus or rituximab.

DelveInsight’s Heparin Induced Thrombocytopenia Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 18 ...

Department of Hematology, Haikou Municipal Hospital and Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, China Pregnancy can lead to the recurrence or ...